subscribeSubscribe
TerSera Canada’s goserelin acetate receives` ER+ early breast cancer canada

TerSera Canada’s goserelin acetate receives` ER+ early breast cancer canada
PHARMABIZ
09 May 2024
Share Share
Health Canada Approves ZOLADEX For ER+ Breast Cancer Management

Health Canada Approves ZOLADEX For ER+ Breast Cancer Management
BUSINESSWIRE
07 May 2024
Share Share
AZ hit with fine in Korea over plot to stall generic of lucrative cancer med

AZ hit with fine in Korea over plot to stall generic of lucrative cancer med
Fraiser Kansteiner FIERCEPHARMA
14 Oct 2022
Share Share
Myovant`s oral prostate cancer drug matches incumbent in phase 3

Myovant`s oral prostate cancer drug matches incumbent in phase 3
N. P Taylor FIERCE BIOTECH
20 Nov 2019
Share Share
Myovant`s oral prostate cancer drug matches incumbent in phase 3

Myovant`s oral prostate cancer drug matches incumbent in phase 3
N. P Taylor FIERCE BIOTECH
20 Oct 2019
Share Share
Myovant`s oral prostate cancer drug matches incumbent in phase 3

Myovant`s oral prostate cancer drug matches incumbent in phase 3
N. P Taylor FIERCE BIOTECH
20 Oct 2019
Share Share
AstraZeneca cuts 94 jobs from UK campus

AstraZeneca cuts 94 jobs from UK campus
Ben Hargreaves IN-PHARMATECHNOLOGIST
27 Mar 2019
Share Share
AstraZeneca sells 3 drugs for $350M upfront

AstraZeneca sells 3 drugs for $350M upfront
Suzanne Elvidge BIOPHARMADIVE
11 Mar 2019
Share Share
Astra`s Soriot Says Slow Pace of Brexit Talks an Area of Concern

Astra`s Soriot Says Slow Pace of Brexit Talks an Area of Concern
John Lauerman BLOOMBERG
06 Sep 2017
Share Share
AstraZeneca to invest £150m in new facility

AstraZeneca to invest £150m in new facility
Marc Hauschild THE MANUFACTURE
05 Sep 2017
Share Share